{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:20Z","timestamp":1761058760745,"version":"3.33.0"},"reference-count":52,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1185\/030079907x242575","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T00:26:29Z","timestamp":1201134389000},"page":"3069-3078","source":"Crossref","is-referenced-by-count":6,"title":["Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK"],"prefix":"10.1185","volume":"23","author":[{"given":"Jeroen P.","family":"Jansen","sequence":"first","affiliation":[{"name":"Mapi Values, Houten, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Pellissier","sequence":"additional","affiliation":[{"name":"Health Economic Statistics, Merck Research Laboratories, Merck & Co., Inc., Blue Bell, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest H.","family":"Choy","sequence":"additional","affiliation":[{"name":"Sir Alfred Baring Garrod Clinical Trials Unit, Academic Department of Rheumatology, GKT School of Medicine, King's College Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Ostor","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Addenbrooke's Hospital, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian T.","family":"Nash","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal National Orthopaedic Hospital, Stanmore and Barnet Hospital, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bacon","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Division of Immunity and Infection, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Hunsche","sequence":"additional","affiliation":[{"name":"Outcome Research, Merck & Co., Inc., Whitehouse Station, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2007,10,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199807000-00003"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.732"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh271"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Sieper J, Braun J. New treatment options in ankylosing spondylitis: a role for anti-TNF\u03b1 therapy. Ann Rheum Dis 2001;60:iii58\u201361","DOI":"10.1136\/ard.60.90003.iii58"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.817"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041129"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Keat A. BSR guideline for prescribing TNF alpha blockers in adults with ankylosing spondylitis. The British Society for Rheumatology, 2004","DOI":"10.1093\/rheumatology\/keh669"},{"key":"CIT0008","volume":"12","author":"Rostom A","year":"2004","journal-title":"Ottawa: Canadian Coordinating Office for Health Technology Assessment, Technology overview no"},{"key":"CIT0009","unstructured":"Jenkins JK, Seligman PJ. FDA decision memo \u2013 analysis and recommendations for agency action \u2013 COX-2 selective and non-selective NSAIDs. 2005. Available from http:\/\/www.fda.gov\/cder\/drug\/infopage\/cox2\/NSAIDdecisionMemo.pdf [Last accessed 28 July 2006]"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/art.20985"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X43686"},{"key":"CIT0012","unstructured":"Laine L, Reicin AS, Yu Q, et al. COX-2 selective inhibitors rofecoxib and etoricoxib decrease serious lower gastrointestinal clinical events compared to non-selective NSAIDs: a meta-analysis. The 11th Asia Pacific League of Associations for Rheumatology Congress. Korea, Jeju, September 11\u201315, 2004, pp. 85\u20136"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/art.10697"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200422100-00003"},{"key":"CIT0015","unstructured":"MediPlus IMS UK, 2003"},{"key":"CIT0016","first-page":"457","volume":"4","author":"Bird HA","year":"1986","journal-title":"Pharmatherapeutica"},{"key":"CIT0017","first-page":"1200","volume":"23","author":"Batlle-Gualda E","year":"1996","journal-title":"al. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group. J Rheumatol"},{"key":"CIT0018","first-page":"118","volume":"14","author":"Khan MA","year":"1987","journal-title":"J Rheumatol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1177\/030006058801600210"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1185\/03007999009112691"},{"issue":"1","key":"CIT0021","first-page":"24","volume":"45","author":"McKenna F","year":"1993","journal-title":"diclofenac in the treatment of ankylosing spondylitis. Drugs"},{"key":"CIT0022","first-page":"1194","volume":"23","author":"Villa Alcazar LF","year":"1996","journal-title":"Spanish Study Group on Aceclofenac in Ankylosing Spondylitis. J Rheumatol"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00267-5"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.3111\/200104001017"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00288.x"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1002\/art.11197"},{"key":"CIT0027","unstructured":"Ware JE. SF-36: the SF-36 community. Available from http:\/\/www.sf-36.org\/tools\/sf36.shtml#CONSTRUCT [Last accessed 10 May 2004]"},{"key":"CIT0028","doi-asserted-by":"crossref","unstructured":"Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making 2001;21: 105\u201312","DOI":"10.1177\/02729890122062352"},{"key":"CIT0029","first-page":"2112","volume":"44","author":"Marzo-Ortega H","year":"2001","journal-title":"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.5.429"},{"volume-title":"No 708","year":"2004","author":"Monthly digest of statistics","key":"CIT0031"},{"key":"CIT0032","unstructured":"Government Actuary\u2019s Department (GAD) interim life tables 1999\u20132001, UK. Available from http:\/\/www.gad.gov.uk\/Life_Tables\/Interim_life_tables.htm [Last accessed 10 Mar 2005]"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh386"},{"key":"CIT0034","doi-asserted-by":"crossref","unstructured":"Briggs A, Sculpher M, Claxton K, editors. Making decision models probabilistic. Decision modelling for health economic evaluation, pp 77\u2013120. Oxford: Oxford University Press, 2006","DOI":"10.1093\/oso\/9780198526629.003.0004"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-7-79"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90007-0"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.4.353"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1002\/art.11121"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90250-1"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199801)41:1<16::AID-ART3>3.0.CO;2-4"},{"key":"CIT0041","first-page":"639","volume":"66","author":"Knill-Jones R","year":"1990","journal-title":"Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J"},{"key":"CIT0042","first-page":"8","volume":"51","author":"Singh G","year":"1998","journal-title":"Arthritis, rheumatism, and aging medical information system. J Rheum"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.3109\/03009749209095099"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300013465"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199508060-00004"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1007\/BF02599040"},{"key":"CIT0047","first-page":"41","volume":"264","author":"Edelson JT","year":"1990","journal-title":"Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. JAMA"},{"key":"CIT0048","first-page":"258","volume":"20","author":"Gabriel SE","year":"1993","journal-title":"Patient preferences for nonsteroidal antiinflammatory drug-related gastrointestinal complications and their prophylaxis. J Rheum"},{"key":"CIT0049","first-page":"447","volume":"36","author":"Gabriel SE","year":"1993","journal-title":"The cost-effectiveness of misoprostol for non-steroidal anti-inflammatory drug-associated adverse gastrointestinal events. Arth Rheum"},{"key":"CIT0050","first-page":"76","volume":"12","author":"Johnson RE","year":"1997","journal-title":"Experience in a US health maintenance organization. Pharmacoeconomics"},{"key":"CIT0051","first-page":"399","volume":"4","author":"Kong SX","year":"1998","journal-title":"Am J Manag Care"},{"key":"CIT0052","unstructured":"Curtis L, Netten A. Unit costs of health and social care 2004. Personal Social Services Research Unit, University of Kent, Canterbury, UK, 2004"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079907X242575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T06:06:19Z","timestamp":1737871579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079907X242575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,1,1]]}},"alternative-id":["10.1185\/030079907X242575"],"URL":"https:\/\/doi.org\/10.1185\/030079907x242575","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"type":"print","value":"0300-7995"},{"type":"electronic","value":"1473-4877"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}